Schizophrenia Trial, Recruiting NCT01409109 Sponsor: University of Texas Southwestern Medical Center Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT01409109
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People with schizophrenia or a related condition:

  • People who have been formally diagnosed with schizophrenia or schizoaffective disorder (based on standard diagnostic guidelines known as DSM-IV-TR)
  • People who are able to understand and agree to take part in the study on their own
  • People of any race or ethnicity
  • People whose vision is at least 20-40, whether naturally or with glasses or contact lenses
  • People who can read, speak, and understand English

Healthy volunteers (no mental illness):

  • People with no past or current serious mental health conditions
  • People of any race or ethnicity
  • People whose vision is at least 20-40, whether naturally or with glasses or contact lenses
  • People who can read, speak, and understand English

Who may not be able to join:

People with schizophrenia or a related condition:

  • People who have been diagnosed with a brain disease caused by a physical or medical condition
  • People who have had a problem with alcohol or drug misuse in the past month, or alcohol or drug dependence in the past three months
  • People who have a serious or unstable physical health condition
  • People with a history of a serious head injury
  • People who are pregnant

Healthy volunteers:

  • People who have a history of any psychiatric (mental health) illness
  • People who are currently using mind-altering drugs (not including nicotine or caffeine)
  • People who have been diagnosed with a brain disease caused by a physical or medical condition
  • People who have a serious or unstable physical health condition
  • People with a history of a serious head injury
  • People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Carol A. Tamminga, M.D., UT Southwestern

Phone: 214-645-8942

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 March 2010
Est. completion
1 April 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Differences in hippocampal subfield activation between people with schizophrenia (or schizoaffective disorder) and healthy volunteers

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov